Cargando…
Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials
Objectives To assess the benefits and harms of reboxetine versus placebo or selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression, and to measure the impact of potential publication bias in trials of reboxetine. Design Systematic review and meta-analysis including unpu...
Autores principales: | Eyding, Dirk, Lelgemann, Monika, Grouven, Ulrich, Härter, Martin, Kromp, Mandy, Kaiser, Thomas, Kerekes, Michaela F, Gerken, Martin, Wieseler, Beate |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954275/ https://www.ncbi.nlm.nih.gov/pubmed/20940209 http://dx.doi.org/10.1136/bmj.c4737 |
Ejemplares similares
-
Completeness of Reporting of Patient-Relevant Clinical Trial Outcomes: Comparison of Unpublished Clinical Study Reports with Publicly Available Data
por: Wieseler, Beate, et al.
Publicado: (2013) -
The selective norepinephrine reuptake inhibitor reboxetine promotes late-stage fracture healing in mice
por: Donat, Antonia, et al.
Publicado: (2023) -
Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study
por: Zheng, Guoxun, et al.
Publicado: (2016) -
Access to regulatory data from the European Medicines Agency: the times they are a-changing
por: Wieseler, Beate, et al.
Publicado: (2012) -
Reboxetine-induced urinary hesitancy
por: Borade, Suresh, et al.
Publicado: (2005)